ABCL Abcellera Biologics Inc
Company Analysis
Latest News
🟢 ABCL makes sharp 10.8% jump
ABCL is trading at $7.38, up 10.8% versus the comparison close of $6.66 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 ABCL Extends Rally, Up 5.5% Today on Momentum from Jazz Pharmaceuticals Collaboration
ABCL is trading 5.5% up at $7.03 today, continuing a multi-day rally fueled by its recently announced preclinical collaboration with Jazz Pharmaceuticals. The...
🟢 ABCL makes sharp 11.1% jump
ABCL is trading at $6.70, up 11.1% versus the comparison close of $6.03 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 ABCL surges 5.4% today, fueled by recent Jazz Pharmaceuticals collaboration
ABCL is trading 5.4% up today at $6.36, extending a strong multi-day run that has lifted the stock more than 20% over the past week. • This rally follows the...
🟢 ABCL makes sharp 10.6% jump
ABCL is trading at $6.22, up 10.6% versus the comparison close of $5.63 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 ABCL is trading 6% up today as it extends its rebound from last week’s gains
ABCL is trading 6% up at $5.97 as it extends its rebound from last week’s strong gains following a recent pullback. • The move appears driven by continued...
🔴 ABCL is trading 5.7% down today as it pulls back from recent gains
ABCL is trading at $5.41 (5.7% down) as it pulls back from recent gains after a strong move higher last week. • The decline occurs in thin pre-market action...
🟢 Abcellera Biologics Inc is trading 5.7% up today after $56M oncology deal with Jazz Pharmaceuticals
Abcellera Biologics Inc is trading at $5.75 (5.7% up) following a new oncology collaboration with Jazz Pharmaceuticals. • The agreement includes $56 million...
AbCellera Announces Oncology Collaboration with Jazz Pharma with $56M in Upfront Payments
AbCellera Biologics has entered into a preclinical research collaboration, option, and license agreement with Jazz Pharmaceuticals to discover and develop...
🟢 Abcellera Biologics Inc makes sharp 10.1% jump
ABCL is trading at $5.61, up 10.1% versus the comparison close of $5.09 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Abcellera Biologics Inc (ABCL) Surges 5.1% on $848M Oncology Partnership with Jazz Pharmaceuticals
• Abcellera announced a significant preclinical research collaboration, option, and license agreement with Jazz Pharmaceuticals to discover and develop...
🟢 Abcellera Biologics Inc is trading 5.11% up today on new board appointment and broad market rally
Abcellera Biologics Inc is trading at $5.51 (+5.11%) in pre-market sessions, driven by the appointment of Victor Sandor as an independent director and a broad...
🔴 Abcellera Biologics Inc is trading 5.5% down today amid a broader market risk-off environment
Abcellera Biologics Inc is trading at $5.12 (5.5% down) amid a broader risk-off environment that is pressuring growth and tech-oriented names. • The decline...
🔴 Abcellera Biologics Inc is trading 10.3% down today as rising yields pressure biotech stocks
Abcellera Biologics Inc is trading 10.3% down at $5.71 as the biotech sector faces pressure from rising Treasury yields and hawkish Fed expectations. • The...
AbCellera Appoints Experienced Oncology Executive Dr. Victor Sandor to its Board
AbCellera Biologics announced the appointment of Victor Sandor, M.D.C.M., to its Board of Directors as a new independent director, effective June 1, 2026. Dr....
🔴 Abcellera Biologics Inc is trading 6.8% down today on profit taking after recent post-earnings rally
Abcellera Biologics Inc is trading 6.8% down today at $5.93 as the stock undergoes consolidation following a significant multi-day rally. • The recent surge...
🟢 Abcellera Biologics Inc is trading 12.6% up today ahead of Jefferies Global Healthcare Conference presentation
Abcellera Biologics Inc is trading 12.6% up at $6.44 as traders position ahead of the company’s presentation at the Jefferies Global Healthcare Conference. •...
Abcellera Pops 7.8% Ahead of Jefferies Conference — But Can a Slide Deck Justify a $1.8 Billion Valuation for a Company That Made $8 Million Last Quarter?
Shares of AbCellera Biologics jumped 7.8% to $6.17 on June 4, rebounding sharply from two straight losing sessions as traders bet the company's presentation at...
🟢 Abcellera Biologics Inc is trading 7.9% up today ahead of Jefferies Global Healthcare Conference presentation
Abcellera Biologics Inc is trading 7.9% up at $6.17 as investors position themselves ahead of the company's scheduled appearance at the Jefferies Global...
🟢 Abcellera Biologics Inc. is trading 3.67% up ahead of its presentation at the Jefferies Global Healthcare Conference
Abcellera Biologics Inc. is trading at $5.93, a gain of 3.67% today, as investors look ahead to the company's presentation at a major investor conference. •...